Pricing Log in Create free account

Ceryvyn Therapeutics Ltd. - Unsponsored ADR (CYVNY) vs Valneva SE Sponsored ADR (VALN)

Ceryvyn Therapeutics Ltd. - Unsponsored ADR and Valneva SE Sponsored ADR are both Biotechnology companies. Ceryvyn Therapeutics Ltd. - Unsponsored ADR and Valneva SE Sponsored ADR are of similar size ($560.4M and $524.8M). Ceryvyn Therapeutics Ltd. - Unsponsored ADR has negative trailing earnings, so its P/E is not meaningful; Valneva SE Sponsored ADR trades at 59.7×. Valneva SE Sponsored ADR has the higher net margin (−12.0% vs −89,724.2%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Valneva SE Sponsored ADR leads on 9 and Ceryvyn Therapeutics Ltd. - Unsponsored ADR on 3.

Valuation

Metric CYVNY VALN Biotechnology median
P/E n/m 59.68 8.50
P/S 2.37 3.05 9.71
P/B n/m 5.30 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 42.91 0.64
EV/Sales 759.28 3.49 9.21
Earnings yield (2,375.00%) 1.68% (33.15%)
Free cash flow yield (84,379.36%) (11.78%) (25.50%)

Profitability

Metric CYVNY VALN Biotechnology median
Gross margin 0.00% 38.28% 65.16%
Operating margin 0.00% 13.56% 0.00%
Net margin (89,724.18%) (12.01%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% 0.00% (56.36%)
Return on assets 0.00% 0.00% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CYVNY VALN Biotechnology median
Revenue growth (TTM) — (53.16%) 6.02%
EPS growth (last fiscal year) 61.59% (805.88%) 30.26%
Revenue growth, 5-year CAGR (15.81%) 9.41% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CYVNY VALN Biotechnology median
Debt to equity 0.00 2.27 0.00
Current ratio 0.22 2.16 4.72
Net debt to EBITDA 0.31 (1.15) 0.96

Dividend

Metric CYVNY VALN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CYVNY VALN Biotechnology median
Market cap 524.83m 560.39m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack